Genzyme Corp. beat consensus earnings estimates for the third quarter, without taking into account the company's purchase of SangStat Medical Corp., and raised its fourth-quarter and year-end financial outlook. (BioWorld Today)

Genzyme Corp. beat consensus earnings estimates for the third quarter, without taking into account the company's purchase of SangStat Medical Corp., and raised its fourth-quarter and year-end financial outlook. (BioWorld Today)